A new USC Schaeffer Center white paper finds expanded access to anti-obesity medications would lead to significant increases ...

A large majority of older Americans feel that health insurance – including Medicare – should cover anti-obesity medications, according to a new University of Michigan study.

A Prime Therapeutics analysis of real-world data has found that medical costs for patients taking GLP-1 drugs for obesity had increased by about $1,338 per member, compared with a matched control ...

As the old saying goes, “an ounce of prevention is worth a pound of cure,” and in my decades of experience in healthcare that ...

“That’s only been accelerated by the rise of adoption of anti-diabetes and anti-obesity medication. People taking GLP-1 drugs ...

Wockhardt will deepen its novel antibiotics pipeline over the next five years and focus on building a biosimilar business for ...

Former Citigroup CEO Sandy Weill has donated $50 million to launch a cancer research hub focusing on how diet and metabolism ...

Older people with obesity and overweight require access to proven treatment options and care to improve overall health and reduce other related health care costs. This briefing will feature medical ...